FREE SHIPPING AND RETURNS ON ALL ORDERS

Your cart

Your cart is empty

Not sure where to start?
Try these SportPort Active collections:

Part III: Deciphering Your Mammogram Results: Your Next Moves Explained

Part III: Deciphering Your Mammogram Results: Your Next Moves Explained

Welcome to the third installment of SportPort Active's esteemed Breast Cancer Awareness, Pink October blog series. For those in pursuit of premium women's activewear that seamlessly blends fashion with functionality, you have arrived at the appropriate destination. Furthermore, this article provides a comprehensive analysis of mammogram results, an essential factor of women's health.

SportPort Active's committed to offering more than just trend setting activewear, we encourage a holistic approach to health and wellness. Our patented EMF-blocking technology acts as a shield, protecting you from the harmful effects of cell phone radiation. Your health is our top priority, and today, we unravel the enigma that is your mammogram results.

Within Approximately One Week: Understanding the Implications

Following a meticulous mammogram procedure, the waiting for results often brings anxiety and concern. Typically, results are disseminated within a week, though occasionally the timeline might extend. Once you’ve received results, they’re categorized into 'normal,' 'benign,' or 'malignant' classifications. It is critical to comprehend the nuances of these classifications to navigate properly through healthcare decisions. We’re here to clarify each classification to facilitate a clearer understanding.

The Optimal Outcome: Normal Results

Receiving a 'normal' designation on your mammogram results is undoubtedly reassuring. However, it's imperative not to misconstrue this as an indefinite assurance. Even with a 'normal' outcome, especially for women with a familial history of breast cancer or other predisposing factors, regular screenings remain paramount. Consistent monitoring and early detection are the foremost strategies in the proactive management of breast health.

Non-Cancerous Findings: Benign Explained

If receiving ‘benign’ results this means that the radiologist found a benign (noncancerous) structure in your breast, such as benign calcifications, cysts, lymph nodes or fibroadenomas. But what precisely does this denote for future health implications? The term 'benign' indicates the presence of irregularities within the breast tissue; however, these are non-cancerous in nature. It's vital to emphasize that 'benign' should not be equated with 'dismiss.' To obtain a comprehensive understanding of these anomalies, your healthcare professional might suggest supplementary imaging or biopsies.

The Grave Implication: Malignant

Receiving a 'malignant' diagnosis undeniably accompanies a profound moment of introspection. The term's inherent gravity is profound. Yet, it is imperative to navigate this revelation with composed pragmatism. Early diagnosis of breast cancer often correlates with a favorable prognosis. Typically, your medical expert will deliberate upon a spectrum of therapeutic interventions. Potential strategies encompass surgical tumor excision, chemotherapy to aimed at exterminating cancerous cells, and radiation therapy targeting the eradication of any residual malignancies. Depending on the cancer's progression and nature, a combination of these treatments might be advised.

Breast Cancer Types

Understanding the diverse types of breast cancer and their specific implications is crucial. Healthcare professionals classify these types and subtypes to customize treatments, maximizing efficacy while minimizing potential side effects.

Common types of breast cancer include:

  • Invasive (infiltrating) ductal carcinoma (IDC): This cancer starts in your milk ducts and spreads to nearby breast tissue. It’s the most common type of breast cancer in the United States.
  • Lobular breast cancer: This breast cancer starts in the milk-producing glands (lobules) in your breast and often spreads to nearby breast tissue. It’s the second most common breast cancer in the United States.
  • Ductal carcinoma in situ (DCIS): Like IDC, this breast cancer starts in your milk ducts. The difference is DCIS doesn’t spread beyond your milk ducts.
  • Less common breast cancer types include:
  • Triple-negative breast cancer (TNBC): This invasive cancer is aggressive and spreads more quickly than other breast cancers.
  • Inflammatory breast cancer (IBC): This rare, fast-growing cancer looks like a rash on your breast. IBC is rare in the United States.
  • Paget’s disease of the breast: This rare cancer affects the skin of your nipple and may look like a rash. Less than 4% of all breast cancers are Paget’s disease of the breast.

Breast Cancer Subtypes

Healthcare providers classify breast cancer subtypes by receptor cell status. Receptors are protein molecules in or on cells’ surfaces. They can attract or attach to certain substances in your blood, including hormones like estrogen and progesterone. Estrogen and progesterone help cancerous cells to grow. Finding out if cancerous cells have estrogen or progesterone receptors helps healthcare providers plan breast cancer treatment.

Subtypes Include:

  • ER-positive (ER+)breast cancers have estrogen receptors.
  • PR-positive (PR+)breast cancers have progesterone receptors.
  • HR-positive (HR+)breast cancers have estrogen and progesterone receptors.
  • HR-negative (HR-)breast cancers don’t have estrogen or progesterone receptors.
  • HER2-positive (HER2+)breast cancers, which have higher than normal levels of the HER2 protein. This protein helps cancer cells to grow. About 15% to 20% of all breast cancers are HER2-positive.

Additional Testing: When a Mammogram Isn't Enough

Occasionally, a mammogram may not capture the full picture, particularly if there's an unusual finding in your results. In such cases, further imaging tests, such as an ultrasound or MRIs, could offer a clearer view of the breast tissue. To get a more detailed view, other imaging techniques like ultrasounds or MRIs might be recommended. If there's a suspicion of malignant cells, a breast biopsy typically follows. This procedure extracts a tiny sample of tissue, allowing for a microscopic analysis to determine the exact nature and progression of the potential cancer.

Understanding BI-RADS

The Breast Imaging-Reporting and Data System (BI-RADS) is your key to deciphering the complex jargon often seen in mammogram reports. The scoring system ranges from 0 to 6 and is universally used by radiologists. Ensure you consult with healthcare providers who have Board Certification and Fellowship Training in Breast Imaging for the most accurate understanding of your mammogram. Here is a comprehensive Mammography FAQ as to better understand Breast Imaging-Reporting and Data System.

Navigating Your Health Pathway

A wellness journey is an enduring commitment, one that demands perpetual awareness and dedication. Regardless of your mammogram's findings, it's essential to see it as a singular checkpoint in your broader health narrative. Expand your protective measures by integrating SportPort Active's advanced EMF-blocking sports bras and sports bra tanks into your everyday attire. Think of it as donning a shield against the unseen hazards of cell phone radiation.

To encapsulate, this third chapter in our Pink October series serves as your comprehensive manual for decoding mammogram outcomes. Every result, whether labeled as normal, benign, or malignant, comes with its unique guidelines. Navigate this map attentively, fortified by the advice of seasoned medical professionals and the security offered by SportPort Active's premium, safeguarding activewear.

Remember, relative of your health, you’re not merely an observer; you're the chief protagonist. With SportPort Active as your trusted ally, stride forward with assurance, aware that we're steadfastly by your side — in every sense of the word.

Helpful Breast Cancer Resources:

American Cancer Society

Breast Cancer Now

City of Hope

Comprehensive Mammogram FAQ

National Breast Cancer Foundation

EMF Protection Sports Bras   

Susan G. Komen Breast Cancer Helpline

Previous post
Next post